SLC5A3 and schizophrenia: Recent studies revealed a strong correlation between the expression of the myo-inositol transporters SMIT1 and SMIT2 and psychiatric diseases, e.g. schizophrenia and bipolar disorder, and it was suggested that alterations in their expression in specific brain regions account for the symptoms of these diseases [188].